Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France.

Macha TetartPriscila PassecountrinAnaïs LesourdDiane SanderinkGwenaël Le MoalLaure SurgersGuillaume BéraudChristine KatlamaOlivier RobineauJean-Jacques Parientinull null

Published in: The Journal of antimicrobial chemotherapy (2023)

Potential DDIs that lead to therapeutic modifications remain significant whatever the age of PLHIV. More devoted time to identify co-medications and OTC treatment is needed in all PLHIV.

Keyphrases

mental health
cross sectional
combination therapy
replacement therapy